Myotonic Dystrophy Consortium Meeting (IDMC-14), Nijmegen, NL, 9-13 April 2024

9 – 13 April 2024

The 2024 edition of the International Myotonic Dystrophy Consortium Meeting (IDMC-14) will be held in Nijmegen from 9-13 April 2024.

#Nijmegen is the oldest city in the Netherlands and one of the places where the disease-causing repeat expansion was identified in the nineties. OPTIMISTIC, the largest #myotonicdystrophy trial, was initiated and coordinated in Nijmegen.

The meeting will offer an excellent opportunity to learn, share, and network with all those currently active in the field of myotonic dystrophy: scientists, clinicians, patients, patient representatives, and professionals from the pharmaceutical industry.
#IDMC14 promises to be a truly unique experience, with cutting-edge presentations, interactive sessions, and engaging discussions that will challenge and inspire you. Participants will have the chance to connect with peers and experts from around the world, exchanging knowledge and ideas that will drive innovation and advancement in our field.

Please visit the website for more information and registration.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit